List view / Grid view
14 June 2012 | By H. Lundbeck A/S
Lundbeck proposes to restructure its commercial organisation in Europe to build a more flexible commercial infrastructure and to maintain cost control...
13 June 2012 | By Alto Marketing
Speeding up research with novel cell manipulation and analysis platforms...
13 June 2012 | By kdm communications limited
Syrris becomes the leading supplier of flow chemistry solutions around the world...
Five Prime Therapeutics, Inc. (“FivePrime”) has entered into research and commercial agreements with BioWa, Inc. and Lonza to use their POTELLIGENT® CHOK1SV Cell Line for the research, development and production of multiple proprietary antibodies in FivePrime’s oncology pipeline.
13 June 2012 | By Novo Nordisk
Focus will be on disease-modifying immunotherapies for type 1 diabetes...
13 June 2012 | By Sanofi
Sanofi granted the award for “Leading Pan-European Quoted Company for Investor Relations”...
13 June 2012 | By Merck
New data from two pivotal Phase III trials...
12 June 2012 | By Eli Lilly and Company
Inaugural award recognizes life-changing impact of 53-year partnership...
12 June 2012 | By
One in four people with type 2 diabetes did not dose their long-acting (basal) insulin correctly...
12 June 2012 | By Eli Lilly and Company
Lilly will increase equity position in Novast by $20 million...
12 June 2012 | By Amgen
Amgen announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals...
12 June 2012 | By Sanofi
Genzyme is developing LEMTRADA in MS in collaboration with Bayer HealthCare...
11 June 2012 | By Sanofi
New results of a large-scale epidemiological program announced...
11 June 2012 | By GlaxoSmithKline
Stiefel has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica Ltd...
11 June 2012 | By Catalent Pharma Solutions
Michael Valazza, to conduct a workshop on “Coordination of Activities and Responsibilities for Solid Dosage Forms”...
